Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) was upgraded by equities researchers at Wall Street Zen to a “sell” rating in a research note issued to investors on Saturday.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Strata Skin Sciences in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $6.00.
Strata Skin Sciences Trading Down 9.1%
Strata Skin Sciences (NASDAQ:SSKN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 13th. The medical device company reported ($0.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.33). Strata Skin Sciences had a negative net margin of 35.13% and a negative return on equity of 266.94%. The business had revenue of $7.70 million for the quarter, compared to analyst estimates of $8.56 million. Research analysts forecast that Strata Skin Sciences will post -1.05 EPS for the current year.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Featured Stories
- Five stocks we like better than Strata Skin Sciences
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- This AI Chip Giant Could Be the Market’s Next Big Winner
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.